OTTAWA – Health Minister Mark Holland urged a committee of senators Wednesday not to tweak the pharmacare bill he carefully negotiated with the NDP earlier this year.
The bill would underpin a potential national, single-payer pharmacare program and allow the health minister to negotiate with provinces and territories to cover some diabetes and contraceptive medications.
It was the result of weeks of political negotiations with the New Democrats, who early this year threatened to pull out of their supply-and-confidence deal with the Liberals unless they could agree on the wording.
“Academics and experts have suggested amendments to this bill to most of us here, I think,” Independent Senator Rosemary Moodie told Holland at a meeting of the Senate’s social affairs committee.
Holland appeared before the committee as it considers the bill. He said he respects the role of the Senate, but that the pharmacare legislation is, in his view, “a little bit different.”
“It was balanced on a pinhead,” he told the committee.
“This is by far — and I’ve been involved in a lot of complex things — the most difficult bit of business I’ve ever been in. Every syllable, every word in this bill was debated and argued over.”
Holland also asked the senators to move quickly to pass the legislation, to avoid lending credence to Conservative critiques that the program is a fantasy.
When asked about the Liberals’ proposed pharmacare program for diabetes and birth control, Conservative Leader Pierre Poilievre has often responded that the program isn’t real. Once the legislation is passed, the minister must negotiate with every provincial government to actually administer the program, which could take many months.
“If we spend a long time wordsmithing and trying to make the legislation perfect, then the criticism that it’s not real starts to feel real for people, because they don’t actually get drugs, they don’t get an improvement in their life,” Holland told the committee.
He told the committee that one of the reasons he signed a preliminary deal with his counterpart in British Columbia was to help answer some of the Senate’s questions about how the program would work in practice.
The memorandum of understanding between Ottawa and B.C. lays out how to province will use funds from the pharmacare bill to expand on its existing public coverage of contraceptives to include hormone replacement therapy to treat menopausal symptoms.
The agreement isn’t binding, and Holland would still need to formalize talks with the province when and if the Senate passes the bill based on any changes the senators decide to make.
This report by The Canadian Press was first published Sept. 18, 2024.
